← Scroll for more →
Financial Statements — MLECW
Balance Sheet
(in millions USD)| Metric | Q2 2025 | Q4 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 1.93 | 5.39 | 0.85 | 2.53 | 6.22 | 10.43 |
| Inventory | 4.84 | 6.28 | 0.39 | 0.47 | -- | -- |
| Total Current Assets | 9.54 | 13.75 | 3.20 | 5.33 | 7.16 | 10.43 |
| Goodwill | 0.28 | 0.26 | 0.25 | 0.25 | -- | -- |
| Total Non-current Assets | 21.84 | 21.04 | 19.29 | 18.72 | 12.83 | 12.74 |
| Total Assets | 31.38 | 34.79 | 22.49 | 24.05 | 19.98 | 23.18 |
| Total Current Liabilities | 6.46 | 8.15 | 12.51 | 12.60 | 8.40 | 11.28 |
| Total Non-current Liabilities* | 22.13 | 19.82 | 1.09 | 1.35 | 0.00 | 0.00 |
| Total Liabilities | 28.58 | 27.97 | 13.60 | 13.95 | 8.40 | 11.28 |
| Retained Earnings | (70.28) | (65.94) | (60.21) | (58.62) | (55.88) | (55.52) |
| Total Stockholder Equity | 2.80 | 6.82 | 8.89 | 10.11 | 11.59 | 11.90 |
← Scroll for more columns →
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2 2025 | Q1 2024 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|
| Total Revenue | 2.64 | 1.74 | -- | -- |
| Research & Development | 0.30 | 0.39 | 0.58 | 0.40 |
| Selling, General & Admin | -- | -- | 0.76 | 0.73 |
| Operating Income | (2.06) | (2.27) | (0.44) | (5.66) |
| Interest Expense | 0.65 | 0.09 | -- | -- |
| Pretax Income | (2.15) | (1.81) | (0.36) | (48.68) |
| Tax Provision | 0.28 | (0.22) | -- | -- |
| Net Income | (2.43) | (1.59) | 49.04 | 48.68 |
| Basic EPS | (0.06) | (0.04) | -- | -- |
| Diluted EPS | (0.06) | (0.04) | -- | -- |
← Scroll for more columns →
Cash Flow Statement
(in millions USD)| Metric | Q2 2025 | Q1 2024 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|
| Operating Cash Flow | (2.02) | (1.74) | (4.85) | (0.58) |
| Investing Cash Flow | (0.36) | -- | (0.15) | (0.07) |
| Financing Cash Flow | (1.07) | (0.13) | 10.00 | 10.00 |
← Scroll for more columns →